[PDF][PDF] Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and …

S Hua, PJ Cabot - Pain physician, 2013 - painphysicianjournal.com
Background: The peripheral immune-derived opioid analgesic pathway has been well
established as a novel target in the clinical pain management of a number of painful …

Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain …

S Hua, PJ Cabot - 2013 - pubmed.ncbi.nlm.nih.gov
Background The peripheral immune-derived opioid analgesic pathway has been well
established as a novel target in the clinical pain management of a number of painful …

[引用][C] Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and …

S Hua, PJ Cabot - Pain Physician, 2013 - espace.library.uq.edu.au
Targeted Nanoparticles that Mimic Immune Cells in Pain Control Inducing Analgesic and
Anti-inflammatory Actions: A Potential Nov Page 1 Background: The peripheral immune-derived …

Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain …

S Hua, PJ Cabot - Pain Physician, 2013 - europepmc.org
Background The peripheral immune-derived opioid analgesic pathway has been well
established as a novel target in the clinical pain management of a number of painful …

Targeted Nanoparticles that Mimic Immune Cells in Pain Control Inducing Analgesic and Anti-inflammatory Actions: A Potential Novel Treatment of Acute and Chronic …

S Hua, PJ Cabot - Pain Physician, 2013 - search.proquest.com
BACKGROUND: The peripheral immune-derived opioid analgesic pathway has been well
established as a novel target in the clinical pain management of a number of painful …